Virtus Lifesci Biotech Etf Profile

BBC Etf  USD 29.26  0.56  1.95%   

Performance

1 of 100

 
Weak
 
Strong
Weak

Odds Of Distress

Less than 9

 
High
 
Low
Low
Virtus LifeSci is trading at 29.26 as of the 15th of October 2024, a 1.95 percent increase since the beginning of the trading day. The etf's open price was 28.7. Virtus LifeSci has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat weak performance during the last 90 days. Equity ratings for Virtus LifeSci Biotech are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 15th of September 2024 and ending today, the 15th of October 2024. Click here to learn more.
Under normal market conditions, the fund will invest not less than 80 percent of its assets in component securities of the index. Virtus Lifesci is traded on NYSEARCA Exchange in the United States. More on Virtus LifeSci Biotech

Moving together with Virtus Etf

  0.71IBB iShares Biotechnology ETFPairCorr
  0.74XBI SPDR SP BiotechPairCorr

Virtus Etf Highlights

Thematic Ideas
(View all Themes)
Business ConcentrationSector ETFs, Health Care ETFs, Health, Virtus (View all Sectors)
IssuerVirtus
Inception Date2014-12-16
BenchmarkLifeSci Biotechnology Clinical Trials Index
Entity TypeRegulated Investment Company
Asset Under Management11.06 Million
Average Trading Valume1,776
Asset TypeEquity
CategorySector
FocusHealth Care
Market ConcentrationDeveloped Markets
RegionNorth America
AdministratorVirtus ETF Solutions, LLC
AdvisorVirtus ETF Advisers LLC
CustodianThe Bank of New York Mellon Corporation
DistributorETF Distributors LLC
Portfolio ManagerMatthew B. Brown, Seth Kadushin
Transfer AgentThe Bank of New York Mellon Corporation
Fiscal Year End31-Oct
ExchangeNYSE Arca, Inc.
Number of Constituents123
Market MakerVirtu Financial
Total Expense0.79
Management Fee0.79
Country NameUSA
Returns Y T D17.37
NameVirtus LifeSci Biotech Clinical Trials ETF
Currency CodeUSD
Open FigiBBG007QVCGG1
In Threey Volatility35.63
1y Volatility38.86
200 Day M A27.2496
50 Day M A27.5953
CodeBBC
Updated At15th of October 2024
Currency NameUS Dollar
Virtus LifeSci Biotech [BBC] is traded in USA and was established 2014-12-16. The fund is classified under Health category within Virtus family. The entity is thematically classified as Sector ETFs. Virtus LifeSci Biotech currently have 18.12 M in assets under management (AUM). , while the total return for the last 3 years was -13.6%.
Check Virtus LifeSci Probability Of Bankruptcy

Geographic Allocation (%)

Sector Allocation

Investors will always prefer to have their portfolios divercified against different sectors. The broad sector allocation increases the possibility of making a profit or at least avoiding a loss. However, this may also reduce the expected return on Virtus Etf. Generally, it depends on diversification level and type but usually, the broader the sector allocation, the less risk can be expected from holding Virtus Etf, and the less return is expected.
Institutional investors that are interested in enforcing a sector tilt in their portfolio can use exchange-traded funds, such as Virtus LifeSci Biotech Etf, as a low-cost alternative to building a custom portfolio. So, using sector ETFs to diversify your portfolio can be a profitable strategy. However, no matter what sectors are desirable at a given time, no single industry should ever make up more than 20 percent of your stock portfolio.

Top Virtus LifeSci Biotech Etf Constituents

AMTIApplied Molecular TransportStockHealth Care
SRNESorrento TherapeStockHealth Care
AVROAVROBIOStockHealth Care
ARRYArray TechnologiesStockIndustrials
RETAReata PharmaceuticalsStockHealth Care
NKTXNkarta IncStockHealth Care
XNCRXencor IncStockHealth Care
ADVMAdverum BiotechnologiesStockHealth Care
More Details

Virtus LifeSci Biotech Risk Profiles

The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Virtus LifeSci. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures.

Virtus LifeSci Against Markets

When determining whether Virtus LifeSci Biotech is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Virtus Etf is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Virtus Lifesci Biotech Etf. Highlighted below are key reports to facilitate an investment decision about Virtus Lifesci Biotech Etf:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Virtus LifeSci Biotech. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
The market value of Virtus LifeSci Biotech is measured differently than its book value, which is the value of Virtus that is recorded on the company's balance sheet. Investors also form their own opinion of Virtus LifeSci's value that differs from its market value or its book value, called intrinsic value, which is Virtus LifeSci's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Virtus LifeSci's market value can be influenced by many factors that don't directly affect Virtus LifeSci's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Virtus LifeSci's value and its price as these two are different measures arrived at by different means. Investors typically determine if Virtus LifeSci is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Virtus LifeSci's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.